Tracking gluten immunoreactive peptides from the grain to the gut and beyond
GLUTENOMICS aims to identify and analyze gluten immunoreactive peptides in human biosamples to improve grain-based food tolerability and prevent wheat-related disorders.
Projectdetails
Introduction
Wheat is one of the pillars for nutrition security worldwide, but the prevalence of wheat-related disorders (WRD) is increasing. Taken together, coeliac disease, non-coeliac gluten sensitivity, and wheat food allergy may affect up to 10% of European individuals. The causes for this increase are still unknown, but involve the intricate interaction of proteolytically resistant gluten immunoreactive peptides (GIP) from wheat, rye, and barley, the human immune system, and yet unknown adjuvants.
Current Challenges
Total GIP can be detected by immunoassays in human plasma, urine, and faeces (biosamples) after gluten consumption. However, the precise molecular structures have not been clarified so far because specific analytical methods are missing.
Project Objectives
The project GLUTENOMICS aims to elucidate the molecular structures of GIP in human biosamples and analyze factors determining their identities and quantities. The objectives include:
- Creating a comprehensive database of GIP and elucidating factors affecting gluten protein digestibility.
- Developing and validating proteomics methods to detect GIP in human biosamples.
- Establishing relations between the GIP profile of raw materials, foods, and human biosamples.
Central Hypothesis
My central hypothesis is that gluten structure and content determine its digestibility, which, in turn, leads to different GIP profiles in biosamples from healthy individuals and WRD patients.
Methodology and Impact
The unique toolbox of methods that I will put in place will provide a fundamentally new understanding of how protein structures govern digestibility and how the resulting peptides pass through the human digestive system.
Future Aspirations
My ambition is to use the findings to tailor grain-based foods towards better tolerability to prevent the initial onset of WRD. Beyond grains, GLUTENOMICS opens significant innovative potential to promote human health through systematically structured, isolated, or designed dietary proteins.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 1.499.988 |
Totale projectbegroting | € 1.499.988 |
Tijdlijn
Startdatum | 1-9-2022 |
Einddatum | 31-8-2027 |
Subsidiejaar | 2022 |
Partners & Locaties
Projectpartners
- KARLSRUHER INSTITUT FUER TECHNOLOGIEpenvoerder
Land(en)
Vergelijkbare projecten binnen European Research Council
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Nanostructure formation during food protein digestion and influence on intestinal transportPRODIGEST aims to enhance sustainable food production by investigating the structural and mechanistic aspects of protein digestion to improve nutrient bioavailability and health outcomes. | ERC Consolid... | € 2.355.741 | 2023 | Details |
3Dwheat, A 3 Dimensional functional genomics approach to identify hidden targets controlling heat stress and priming in wheatThis project aims to enhance heat stress resistance in wheat by developing a tri-dimensional functional genomics approach to understand epigenetic mechanisms and create innovative breeding tools. | ERC Consolid... | € 1.999.995 | 2022 | Details |
Defusing mini-chromosomes—the Achilles’ heel of the wheat blast pandemicThe PANDEMIC project aims to develop non-transgenic wheat disease resistance by targeting a unique mini-chromosome in the virulent wheat blast fungus using gene editing and biophysical analysis. | ERC Starting... | € 1.499.999 | 2023 | Details |
Proteome-wide Functional Interrogation and Modulation of Gut Microbiome SpeciesThis project aims to identify and manipulate gut microbiome protein functions using high-throughput proteomics to develop targeted therapies for restoring microbial health. | ERC Starting... | € 1.499.980 | 2023 | Details |
Exploring functional inter-individual variations in the intestinal microbiome for personalized nutritionThe InterBiome project aims to explore how dietary components affect individual microbiota variations, influencing health outcomes and paving the way for personalized medicine and dietary strategies. | ERC Consolid... | € 2.000.000 | 2025 | Details |
Nanostructure formation during food protein digestion and influence on intestinal transport
PRODIGEST aims to enhance sustainable food production by investigating the structural and mechanistic aspects of protein digestion to improve nutrient bioavailability and health outcomes.
3Dwheat, A 3 Dimensional functional genomics approach to identify hidden targets controlling heat stress and priming in wheat
This project aims to enhance heat stress resistance in wheat by developing a tri-dimensional functional genomics approach to understand epigenetic mechanisms and create innovative breeding tools.
Defusing mini-chromosomes—the Achilles’ heel of the wheat blast pandemic
The PANDEMIC project aims to develop non-transgenic wheat disease resistance by targeting a unique mini-chromosome in the virulent wheat blast fungus using gene editing and biophysical analysis.
Proteome-wide Functional Interrogation and Modulation of Gut Microbiome Species
This project aims to identify and manipulate gut microbiome protein functions using high-throughput proteomics to develop targeted therapies for restoring microbial health.
Exploring functional inter-individual variations in the intestinal microbiome for personalized nutrition
The InterBiome project aims to explore how dietary components affect individual microbiota variations, influencing health outcomes and paving the way for personalized medicine and dietary strategies.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
First ever preventive treatment for celiac disease and gluten sensitivityE40 is a novel gluten-degrading enzyme designed to improve quality of life for Celiac and gluten-sensitive individuals by reducing gluten's inflammatory effects during digestion. | EIC Accelerator | € 2.499.999 | 2023 | Details |
Precision Nutrition to optimize immune response for metabolic healthNUTRIMMUNE investigates the impact of precision nutrition on immune responses in obesity-related NCDs, aiming to establish dietary recommendations through multi-omics analysis and intervention studies. | EIC Pathfinder | € 4.318.432 | 2024 | Details |
Glucose variability patterns for precision nutrition in diabetesThe GLUCOTYPES project aims to identify early glycaemic patterns and their dietary influences using advanced technologies to develop precision nutrition strategies for Type 2 diabetes prevention and management. | EIC Pathfinder | € 3.988.206 | 2024 | Details |
Novel First-in-Class Specific Oromucosal Immunotherapy (SOMIT) to treat Celiac Disease (CD)The project aims to develop a novel treatment for celiac disease using a combination of gliadin protein, probiotic particles, and mouth patch technology, targeting market entry by 2029. | EIC Accelerator | € 2.499.993 | 2022 | Details |
Bugs4Urate - Precision Nutrition Strategies for Investigating Probiotic, Diet, Glycan, and Microbiome Factors in Hyperuricemia and Gout PreventionThis project aims to develop a precision nutrition approach using a novel probiotic to lower urate levels and prevent gout by analyzing gut microbiome interactions and individual responses. | EIC Pathfinder | € 3.765.840 | 2024 | Details |
First ever preventive treatment for celiac disease and gluten sensitivity
E40 is a novel gluten-degrading enzyme designed to improve quality of life for Celiac and gluten-sensitive individuals by reducing gluten's inflammatory effects during digestion.
Precision Nutrition to optimize immune response for metabolic health
NUTRIMMUNE investigates the impact of precision nutrition on immune responses in obesity-related NCDs, aiming to establish dietary recommendations through multi-omics analysis and intervention studies.
Glucose variability patterns for precision nutrition in diabetes
The GLUCOTYPES project aims to identify early glycaemic patterns and their dietary influences using advanced technologies to develop precision nutrition strategies for Type 2 diabetes prevention and management.
Novel First-in-Class Specific Oromucosal Immunotherapy (SOMIT) to treat Celiac Disease (CD)
The project aims to develop a novel treatment for celiac disease using a combination of gliadin protein, probiotic particles, and mouth patch technology, targeting market entry by 2029.
Bugs4Urate - Precision Nutrition Strategies for Investigating Probiotic, Diet, Glycan, and Microbiome Factors in Hyperuricemia and Gout Prevention
This project aims to develop a precision nutrition approach using a novel probiotic to lower urate levels and prevent gout by analyzing gut microbiome interactions and individual responses.